Analysis 1.28.

Comparison 1 Anti‐leukaemic therapy plus anti‐CD20 versus anti‐leukaemic therapy alone (anti‐leukaemic therapy identical in both groups), Outcome 28 Grade 3/4 AEs ‐ overall analysis.

Comparison 1 Anti‐leukaemic therapy plus anti‐CD20 versus anti‐leukaemic therapy alone (anti‐leukaemic therapy identical in both groups), Outcome 28 Grade 3/4 AEs ‐ overall analysis.